TURNING POINT BRANDS ($TPB) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of $0.91 per share, beating estimates of $0.79 by $0.12. The company also reported revenue of $106,440,000, beating estimates of $96,711,287 by $9,728,713.
You can see Quiver Quantitative's $TPB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TURNING POINT BRANDS Hedge Fund Activity
We have seen 113 institutional investors add shares of TURNING POINT BRANDS stock to their portfolio, and 73 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 478,320 shares (+12436.8%) to their portfolio in Q4 2024, for an estimated $28,747,032
- MORGAN STANLEY removed 235,702 shares (-18.7%) from their portfolio in Q4 2024, for an estimated $14,165,690
- PARK WEST ASSET MANAGEMENT LLC removed 189,034 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $11,360,943
- LORD, ABBETT & CO. LLC removed 154,876 shares (-63.4%) from their portfolio in Q4 2024, for an estimated $9,308,047
- MILLENNIUM MANAGEMENT LLC removed 128,148 shares (-36.6%) from their portfolio in Q4 2024, for an estimated $7,701,694
- THRIVENT FINANCIAL FOR LUTHERANS removed 116,313 shares (-15.4%) from their portfolio in Q4 2024, for an estimated $6,990,411
- FIRST SABREPOINT CAPITAL MANAGEMENT LP added 105,797 shares (+60.7%) to their portfolio in Q4 2024, for an estimated $6,358,399
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TURNING POINT BRANDS Analyst Ratings
Wall Street analysts have issued reports on $TPB in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Alliance Global Partners issued a "Buy" rating on 03/06/2025
To track analyst ratings and price targets for TURNING POINT BRANDS, check out Quiver Quantitative's $TPB forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
